Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Exercise Test × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Obesity 1 Lymphoma, Non-Hodgkin 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Heart Defects, Congenital 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Carcinoma, Transitional Cell 1

Interventions

Nivolumab 5 pembrolizumab 4 Specimen Handling 4 Biopsy 4 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 avelumab 2 Immunoglobulin G 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 regorafenib 1 prednylidene 1 deltacortene 1 decitabine and cedazuridine drug combination 1 atezolizumab 1 aldesleukin 1 aflibercept 1 X-Rays 1 Sirolimus 1 Radiosurgery 1 Prednisone 1 Paclitaxel 1 NEO212 1 MAPRE1 protein, human 1 Lidocaine, Prilocaine Drug Combination 1 IFL protocol 1 Disulfides 1 Cyclophosphamide 1 Colony-Stimulating Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡